| |
Online pharmacy of generic drugs for pain relief
The main group of painkillers are different in chemical structure and mechanism of action of medicinal substances. Among the main drugs of pain are analgesics. Distinguish non-narcotic and narcotic analgesics. For non-narcotic analgesics include various synthetic drugs (analginum, acetylsalicylic acid, butadion, paracetamol, etc.). Compared with the narcotic analgesics, they have less assuager activity and are effective mainly for pain arising from inflammatory lesions in various organs and tissues.
|
|
 |
Pharmacy news
25.05.2011
Home-Based Medication Management System Looks to Future
BETHESDA, MD 25 May 2011—A federally recognized program that uses pharmacists` medication therapy management skills is targeting hospital-to-home transitions in an attempt... |
|
25.05.2011
Fairleigh Dickinson, Medco Combine Forces to Modernize Pharmacy Practice
BETHESDA, MD 25 May 2011—The vision for the Medco School of Pharmacy at Fairleigh Dickinson University (FDU) in Madison, New Jersey, when it opens next fall, is to produce... |
|
13.05.2011
FDA Sets Priorities for Teva`s Sterile Manufacturing Facility
BETHESDA, MD 13 May 2011—Teva Pharmaceutical Industries Limited, whose sterile products facility in California ceased production a year ago, revealed earlier this week that... |
|
03.05.2011
Bristol-Myers Squibb Recalls Coumadin 5-mg Tablets, Lot 9H49374A
BETHESDA, MD 03 May 2011—Bristol-Myers Squibb Company on May 2 announced a recall (PDF) of Coumadin 5-mg tablets in lot 9H49374A because a company-conducted test of a tablet... |
|
29.04.2011
FDA Approves Prostate Cancer Treatment That Inhibits Testosterone Synthesis
BETHESDA, MD 29 April 2011—Abiraterone acetate, whose active metabolite inhibits an enzyme necessary for the biosynthesis of testosterone, was approved Thursday by FDA for... |
|
29.04.2011
Pharmacists in Arkansas to Judge Individuals` Need for Pseudoephedrine
BETHESDA, MD 29 April 2011—In the battle to cut off the supply of pseudoephedrine to illicit methamphetamine manufacturers, one state is turning to pharmacists to keep the... |
|
19.04.2011
No New Pharmacist Responsibilities With Upcoming Opioid REMS
BETHESDA, MD 19 April 2011—FDA today said the forthcoming risk evaluation and mitigation strategy (REMS) for long-acting and extended-release opioid products will entail... |
|
18.04.2011
Experts Seek Better Understanding of Drug-Induced Liver Injury
SILVER SPRING, MD 18 April 2011—Hepatology experts say they want to be able to know ahead of time which patients are susceptible to idiosyncratic drug-induced liver injury... |
|
18.04.2011
Pharmacy Practice Models Get Improved
BETHESDA, MD 18 April 2011—The practice of pharmacy in hospitals and health systems has more than one model, and the process of changing, redefining, or refining a practice... |
|
15.04.2011
Teva`s Lansoprazole Tablets Can Clog Feeding Tubes, FDA Warns
BETHESDA, MD 15 April 2011—Teva Pharmaceuticals has stopped distributing lansoprazole delayed-release orally disintegrating tablets because of dissolution problems causing... |
|
|
 |
|
|
